Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs

As reported by Share Market Today

Qualifying speciality medicines from India will be eligible for zero duty, providing some relief to Indian drugmakers with exposure to the US market.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Share Market Today ↗

Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.

COMPANIES NCC shares rally 5% after securing Rs 1,076 crore Andhra Pradesh drinking water project Stocks-Markets-Economic Times
COMPANIES Power Mech Projects shares gain 3% after securing Rs 279 crore order from Telangana Power Generation Corporation Stocks-Markets-Economic Times
INDIAN Summit stock surges on $2 billion AstraZeneca investment Markets-Economic Times
INDIAN Azad Engineering Ltd leads gainers in 'A' group Share Market Today
INDIAN Krsnaa Diagnostics board OKs sale of select diagnostic equipment for Rs 120 crore Share Market Today
INDIAN Indices pare some losses; consumer durables shares decline Share Market Today
INDIAN Nifty monthly expiry meets CAS today: Why the last 30 minutes of the Tuesday trading session could be most important mint - markets
INDIAN 26% dip in YTD! Jio Financial Services shares hit 52-week low — will trend reverse? Target price, support, resistance mint - markets

Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs

More from Market Samachar